SKI Market

Indian Indices

Sensex

76,863.71 -1,342.27
( -1.72%)

Global Indices

Nasdaq

47,717.90 -43.91
(-0.09%)

Dow Jones

6,802.01 -14.98
(-0.22%)

Hang Seng

55,018.23 769.84
(1.42%)

Nikkei 225

10,395.67 146.15
(1.43%)

Forex

USD-INR

92.14 0.30
(0.32%)

EUR-INR

106.58 -0.02
(-0.02%)

GBP-INR

123.09 0.04
(0.04%)

JPY-INR

0.58 0.00
(0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Sandu Pharmaceuticals standalone net profit rises 4.00% in the September 2025 quarter

Nov 13,2025

Net profit of Sandu Pharmaceuticals rose 4.00% to Rs 0.52 crore in the quarter ended September 2025 as against Rs 0.50 crore during the previous quarter ended September 2024. Sales declined 0.45% to Rs 17.62 crore in the quarter ended September 2025 as against Rs 17.70 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	17.62	17.70	0
OPM %	4.88	5.14	-
PBDT	0.88	0.91	-3
PBT	0.71	0.74	-4
NP	0.52	0.50	4

76,863.71 -1,342.27 ( -1.72%)

47,717.90 -43.91 (-0.09%)

6,802.01 -14.98 (-0.22%)

55,018.23 769.84 (1.42%)

10,395.67 146.15 (1.43%)

92.14 0.30 (0.32%)

106.58 -0.02 (-0.02%)

123.09 0.04 (0.04%)

0.58 0.00 (0.05%)